Allex
Withdrawn
This medicine's authorisation has been withdrawn
desloratadine
MedicineHumanWithdrawn
- Application under evaluation
- CHMP opinion
- European Commission decision
Overview
The marketing authorisation for Allex has been withdrawn at the request of the marketing authorisation holder.
Product information
31/12/2009
This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
Product details
- Name of medicine
- Allex
- Active substance
- desloratadine
- International non-proprietary name (INN) or common name
- desloratadine
- Therapeutic area (MeSH)
- Rhinitis, Allergic, Perennial
- Urticaria
- Rhinitis, Allergic, Seasonal
- Anatomical therapeutic chemical (ATC) code
- R06AX27
Pharmacotherapeutic group
Antihistamines for systemic useTherapeutic indication
Aerius is indicated for the relief of symptoms associated with:
- allergic rhinitis (see section 5.1)
- urticaria (see section 5.1)
This page was last updated on